Healthcare · NSE: MAXHEALTH · BSE: 543220
Max Healthcare: how the business works
Max Healthcare runs private hospitals, mainly in metro cities and especially Delhi NCR, and earned ₹8,373 crore of consolidated revenue in FY26.
Follow Max Healthcare
Email me when Max Healthcare's page is updated after results.
We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.
Max Healthcare Institute Limited · Mumbai, Maharashtra (registered office) · Founded 2001
Updated for Q2 FY27 · checked
- Revenue, FY26
- ₹8,373 cr
- Profit, FY26
- ₹1,442 cr
- Operational beds, 30 Sep 2026 (network incl. partner hospitals, company's measure)
- 5,518
- Incorporated
- 2001
- Promoter holding, Sep 2026
- 23.71%
The short version
Max Healthcare in 5 points
1 · What it sells
Max Healthcare runs private hospitals, mainly in metro cities, with 5,518 operational beds in its network (incl. partner hospitals) on 30 Sep 2026, and its FY26 consolidated revenue was ₹8,373 crore.
2 · Who pays it
In Q2 FY27, self-paying patients and insurers or employers together paid 71.4% of network hospital revenue, government and institutional schemes 18.4% and international patients 10.2%, and the split between self-pay and insurance is not available on this page.
3 · What it keeps from ₹100
Of every ₹100 that came in during FY26, Max Healthcare kept ₹16.9 as profit, helped by a one-time tax gain of about ₹142 crore net (about ₹149 crore booked in Q2 FY26, about ₹7 crore reversed in Q4 FY26), while its operating profit before interest, tax and depreciation (EBITDA) was ₹26.2 per ₹100 of revenue.
4 · Where the operating profit comes from
Max Healthcare reports a single business segment, medical and healthcare services in India, so its FY26 EBITDA of ₹2,195 crore came from hospital care, diagnostics and home care together.
5 · The one thing to watch
Network operational beds rose to 5,518 on 30 Sep 2026 from 4,760 a year earlier, while borrowings excluding leases rose from ₹565 crore on 31 Mar 2023 to ₹2,907 crore on 31 Mar 2026.
Sources: From Max Healthcare's FY26 annual report, its Q2 FY27 results and earnings update, and its Sep 2026 shareholding pattern · checked
Sources (6)
01Where the money goes · FY26
Where does ₹100 of Max Healthcare's money go?
Max Healthcare · FY26
Receipt for every ₹100
| Drugs, consumables and implants | ₹21.0 |
|---|---|
| Doctors' fees | ₹21.0 |
| Employees | ₹15.9 |
| Other running costs and one-offs | ₹14.5 |
| Depreciation and interest | ₹8.0 |
| Income tax | ₹2.7 |
| Kept as profit | ₹16.9 |
| Total | ₹100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly ₹100 because of rounding.
How this is worked out
Cityfort calculation from the FY26 annual report: each line ÷ total money in (revenue ₹8,373 crore + other income ₹163 crore) × 100. Tax is low because FY26 includes a one-time tax gain of about ₹142 crore net (about ₹149 crore in Q2 FY26, less about ₹7 crore reversed in Q4 FY26).
Save this receipt as an image
Embed this receipt or the key numbers
Paste this code into a blog or website to show the card you choose, with a link back to this page.
Each week: the next company due to report results, explained in 5 points.
We'll email you once a week with what changed on Cityfort. Facts only, no tips. Unsubscribe any time.
We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.
02The business in one line
What does Max Healthcare do?
Patients, insurers and government health schemes pay Max Healthcare for hospital care; drugs and doctors' fees take about ₹42 of every ₹100, and ₹16.9 is left as profit.
- Max Healthcare's press releases headline "network" figures that include partner hospitals owned by societies it does not control. This page uses consolidated figures unless it says network.
- Network operational beds rose from 4,760 to 5,518 in the year to 30 Sep 2026. The company's Aug 2026 presentation plans over 10,000 beds by FY30.
03Who pays it
Who pays Max Healthcare?
Self-paying patients and insurers or employers
71.4%
of revenue
Patients who pay themselves, or whose health insurer or employer pays. The company's chart does not let this page split the two, so they are shown together.
Government and institutional schemes
18.4%
of revenue
Schemes such as CGHS (central government staff) and ECHS (ex-servicemen). Their share fell from 21.5% a year earlier, after CGHS and ECHS disempanelled certain hospitals.
International patients
10.2%
of revenue
Patients who travel from other countries for treatment. Their share rose from 9.2% a year earlier.
- Self-paying patients and insurers or employers71.4%
- Government and institutional schemes18.4%
- International patients10.2%
How spread out the customers are
Shares are of Q2 FY27 network hospital revenue (incl. partner hospitals, excluding Max Lab and Max@Home), as the company reports them. The split between self-pay and insurance is not available on this page.
04How it makes money
How does Max Healthcare make money?
Profit depends on filling the beds it already has, and on how much each patient's treatment brings in.
A hospital's building, equipment and staff cost money whether beds are full or not. Network occupancy was 74–77% in each of the last eight quarters. New beds start empty: Abhay Soi said on 3 Nov 2026 that ramping up new Max Smart beds weighed on the Saket complex's Q2 FY27 EBITDA.
EBITDA per ₹100 of revenue (Cityfort calculation from the annual reports)
₹23.8₹26.2
FY22 to FY26
- Max builds or buys hospitals in big cities.
- Doctors and specialties such as transplants and cancer care bring in patients.
- Patients, insurers and schemes pay for treatment and stays.
- Filled beds spread fixed costs; network occupancy was 77% in Q2 FY27.
- Cash from operations (₹1,633 crore in FY26) and borrowing pay for new beds.
- New beds start empty and need time to fill.
↺ Step 6 feeds back into step 1.
05The numbers · Consolidated · ₹ crore
How has Max Healthcare done?
Revenue
₹8,373 crFY26
Revenue rose every year, from ₹3,937 crore in FY22 to ₹8,373 crore in FY26, and Q2 FY27 revenue was ₹2,569 crore against ₹2,135 crore a year earlier.
₹ crore
See the numbers
Net profit
₹1,442 crFY26
FY26 profit of ₹1,442 crore includes a one-time tax gain of about ₹142 crore net (about ₹149 crore booked in Q2 FY26, about ₹7 crore reversed in Q4 FY26).
₹ crore
See the numbers
Net profit for every ₹100 of revenue
₹17.2FY26
Net profit per ₹100 of revenue was highest in FY23 (₹24.2), a year with a ₹40 crore tax credit, and was ₹17.2 in FY26; EBITDA is a Cityfort calculation (profit before tax + interest + depreciation − other income).
Net margin: ₹ of net profit per ₹100 of revenue
See the numbers
Free cash flow
₹149 crFY26
Operating cash flow rose from ₹741 crore in FY22 to ₹1,633 crore in FY26, but ₹1,485 crore of capex on new beds left ₹149 crore of free cash flow.
₹ crore · cash from operations minus spending on plants and equipment
See the numbers
See all yearly numbers
EBITDA = profit before interest, tax and wear-and-tear of assets. Financial year runs April to March (March year end). Net profit is the share belonging to the company's owners.
Sources (20)
- Annual Report FY23
- Q4 FY22 / FY22 consolidated results, XBRL (FY22 as first reported)
- Annual Report FY24
- Q4 FY23 / FY23 consolidated results, XBRL (cross-check of FY23)
- Annual Report FY25
- Q4 FY24 / FY24 consolidated results, XBRL (cross-check of FY24)
- Integrated Annual Report FY26
- Q4 FY26 / FY26 consolidated results, XBRL (integrated filing)
- Press release and Earnings Update, Q4 FY26
- Q3 FY25 consolidated results, XBRL
- Q4 FY25 / FY25 consolidated results, XBRL (integrated filing)
- Q1 FY26 consolidated results, XBRL (integrated filing)
- Q2 FY26 consolidated results, XBRL (integrated filing)
- Q3 FY26 consolidated results, XBRL (integrated filing)
- Q3 FY26 results (board outcome, quarter ended 31 Dec 2025)
- Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift)
- Q1 FY27 results (board outcome, quarter ended 30 Jun 2026)
- Q1 FY27 consolidated results, XBRL (integrated filing)
- Q2 FY27 consolidated results, XBRL (integrated filing)
- Q2 FY27 results (board outcome, quarter and half-year ended 30 Sep 2026)
06Who runs it
Who runs Max Healthcare, and did they deliver?
Abhay Soi
Chairman & Managing Director
Promoter; held 23.70% of shares on 30 Sep 2026. He was promoter and CMD of Radiant Life Care before the 2020 merger.
Yogesh Kumar Sareen
Chief Financial Officer
Dhiraj Aroraa
Company Secretary
What they said, and what happened
1 missed · 2 partly delivered · 2 delivered
Said on 6 Feb 2026
Commission the first phase of the 500-bed Sector-56, Gurgaon hospital by the end of H1 FY27.
MissedWhat happened
H1 FY27 ended on 30 Sep 2026. On the 3 Nov 2026 call management said it expects to start phased commissioning by the end of FY27.
Said on 6 Feb 2026
Take Max Lucknow from 413 beds to around 500 beds by the end of FY26.
Partly deliveredWhat happened
On 3 Nov 2026 management said 100 beds "in the existing 468-bed facility will be commissioned over the next 2 quarters".
Said on 21 May 2026
Open the rest of the 280-bed Nanavati-Max tower, where 116 beds were running, over the next 3 months.
Partly deliveredWhat happened
On 3 Nov 2026 management said the balance 205 beds at Max Nanavati and Max Smart will open after Diwali puja.
Said on 8 Apr 2026
Buy about 58.39% of Kalinga Hospital, Bhubaneswar, for about ₹300 crore.
DeliveredWhat happened
Max completed the purchase of 58.28% on 18 May 2026 for ₹297.97 crore in cash.
Said on 13 Sep 2024
Acquire Jaypee Healthcare, owner of a 500-bed hospital in Noida, together with the Lakshdeep Group.
DeliveredWhat happened
Max acquired 63.65% on 4 Oct 2024 and the remaining 36.35% on 11 Nov 2024.
Sources (10)
- Integrated Annual Report FY26
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Annual Report FY21 (year of the 2020 merger and listing)
- Earnings call transcript, Q3 FY26 (call 6 Feb 2026)
- Earnings call transcript, Q2 FY27 (call 3 Nov 2026)
- Press release and Earnings Update, Q4 FY26
- Board outcome: agreement to acquire ~58.39% of Kalinga Hospital Ltd, Bhubaneswar (8 Apr 2026)
- Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift)
- Strategic collaboration with Lakshdeep Group to acquire Jaypee Healthcare Ltd (13 Sep 2024)
- Board outcome: fund infusion in Jaypee Healthcare, Nirogi trust and Eqova (30 Jan 2025)
07What could go wrong
What could go wrong for Max Healthcare?
- Concentration
Most beds in one region
Hospitals in the Delhi region had 2,676 of 5,518 operational network beds in Q2 FY27. CARE names concentration in metros, especially Delhi NCR, as a weakness.
Watch Beds outside Delhi as Lucknow, Pune, Mohali and Bhubaneswar projects open.
- Regulation
Government price controls
CARE notes that hospitals are a regulated industry, and that past price caps on stents and knee implants hurt margins.
Watch New price caps on drugs, devices or procedures.
- Demand
Payers can drop hospitals from their lists
CGHS and ECHS disempanelled certain Max hospitals, and their share of network hospital revenue fell from 21.5% to 18.4% in a year. In Q2 FY26 cashless service for some standalone health insurers' customers was disrupted, the company says.
Watch The institutional share of hospital revenue (18.4% in Q2 FY27).
- Execution
A large building plan
The Aug 2026 presentation estimates ₹6,961 crore of spending on new beds from FY27 to FY30, excluding land. The Gurgaon hospital's first phase has already moved from H1 FY27 to the end of FY27.
Watch Operational beds each quarter against the 601 beds planned for FY27.
- Debt
Rising borrowings
Borrowings excluding leases rose from ₹565 crore on 31 Mar 2023 to ₹2,907 crore on 31 Mar 2026. FY26 free cash flow was ₹149 crore.
Watch Borrowings and free cash flow in the FY27 accounts.
- Governance
Money tied to hospitals it does not control
Partner hospitals are owned by societies, and their figures in the network numbers are unaudited. The company says it has significant financial exposure to them, and it lent ₹420 crore to other healthcare providers in FY26.
Watch Loans to other healthcare providers in the cash flow statement.
- Legal
Tribunal case over Kalinga Hospital
Legal representatives of BRS Capital Two Pte. Limited filed petitions at NCLT Cuttack against Kalinga Hospital, its selling shareholder and Max Healthcare. The matter is listed for 14 Dec 2026.
Watch The company's filings after the 14 Dec 2026 listing.
- Competition
Competition from other hospital chains
CARE describes high competition from established brands such as Fortis, Apollo and Medanta. Rivals adding beds in the same cities could slow how fast new Max beds fill.
Watch Network occupancy (77% in Q2 FY27).
Sources (8)
- Press release and Earnings Update, Q2 FY27
- CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025)
- Investor presentation, Motilal Oswal Global Investor Conference (Aug 2026)
- Earnings call transcript, Q3 FY26 (call 6 Feb 2026)
- Earnings call transcript, Q2 FY27 (call 3 Nov 2026)
- Annual Report FY24
- Integrated Annual Report FY26
- Reg. 30 update: NCLT Cuttack petitions by BRS Capital Two Pte relating to Kalinga Hospital, next date 14 Dec 2026 (3 Nov 2026)
08Supporters and critics
What do supporters and critics point to?
What supporters point to
- Consolidated revenue rose every year, from ₹3,937 crore in FY22 to ₹8,373 crore in FY26.
- Network occupancy stayed between 74% and 77% in each of the eight quarters to Q2 FY27, while beds were added.
- International patient revenue rose to ₹307 crore in Q2 FY27, from ₹231 crore a year earlier.
- CARE reaffirmed AA+ (Stable) on the long-term bank facilities in Oct 2026.
- No promoter shares were pledged in any of the 12 quarters to Sep 2026.
What critics point to
- Free cash flow fell to ₹149 crore in FY26 as capex reached ₹1,485 crore, and borrowings rose to ₹2,907 crore.
- Headline network revenue (₹3,219 crore in Q2 FY27) includes partner hospitals Max does not own; consolidated revenue was ₹2,569 crore.
- Hospitals in the Delhi region had 2,676 of 5,518 operational network beds in Q2 FY27.
- The Gurgaon hospital's first phase moved from H1 FY27 to the end of FY27.
- From Q2 FY27 the company stopped reporting revenue per occupied bed.
09What to watch next
What should you watch next at Max Healthcare?
Next event
Q3 FY27 results
Date not announced yet.
Gurgaon Sector-56 hospital
Management said on 3 Nov 2026 it expects to start phased commissioning of the 500-bed hospital by the end of FY27.
Remaining beds at Max Smart and Nanavati
Management said the balance 205 beds at these two hospitals will open after Diwali puja. Network operational beds were 5,518 on 30 Sep 2026.
Kalinga Hospital case
NCLT Cuttack listed the petitions involving Kalinga Hospital and Max Healthcare for 14 Dec 2026.
10Key facts
Key facts about Max Healthcare
- What does Max Healthcare do?
- Max Healthcare Institute Ltd runs private hospitals in India, mainly in metro cities and especially Delhi NCR. It also runs Max Lab (diagnostic tests) and Max@Home (care at home). Max Healthcare's FY26 consolidated revenue was ₹8,373 crore.
- How does Max Healthcare make money?
- Max Healthcare charges patients, insurers and government schemes for treatment, surgery, tests and hospital stays. In FY26 Max Healthcare spent about ₹21 of every ₹100 that came in on drugs and consumables and ₹21 on doctors' fees, and kept ₹16.9 as profit.
- Who pays Max Healthcare?
- In Q2 FY27, self-paying patients and insurers or employers together paid 71.4% of Max Healthcare's network hospital revenue. Government and institutional schemes such as CGHS and ECHS paid 18.4%, and international patients 10.2%.
- How big is Max Healthcare?
- Max Healthcare's FY26 consolidated revenue was ₹8,373 crore and its profit ₹1,442 crore. On 30 Sep 2026 Max Healthcare's network, including partner hospitals, had 5,518 operational beds and 6,184 beds of capacity.
- Who owns Max Healthcare?
- On 30 Sep 2026 Max Healthcare's promoter group held 23.71%, almost all through chairman Abhay Soi, with no shares pledged. Foreign investors held 40.52%, Indian institutions 31.00% and other shareholders 4.76%.
- How did Max Healthcare get listed?
- Max Healthcare did not list through an IPO. NCLT Mumbai sanctioned a merger scheme with Radiant Life Care and Max India on 17 Jan 2020. Max Healthcare's shares then listed on NSE and BSE on 21 Aug 2020.
- Does Max Healthcare have debt?
- On 31 Mar 2026 Max Healthcare had ₹2,907 crore of borrowings, excluding leases, and ₹701 crore of cash and bank balances. CARE Ratings reaffirmed Max Healthcare's long-term bank facilities at CARE AA+ (Stable) in Oct 2026.
- What are Max Healthcare's partner hospitals?
- Max Healthcare's partner hospitals are owned by societies, such as Balaji, GM Modi and Devki Devi, that Max Healthcare does not control. Max Healthcare runs them under service agreements, so their revenue is outside its consolidated revenue but inside its network figures.
- What dividend did Max Healthcare declare for FY26?
- Max Healthcare's board recommended a dividend of ₹2.00 per share for FY26 on 21 May 2026, against ₹1.50 for FY25. That was 13.5% of Max Healthcare's FY26 basic earnings per share of ₹14.83.
Sources (8)
- Integrated Annual Report FY26
- Press release and Earnings Update, Q2 FY27
- CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025)
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Annual Report FY21 (year of the 2020 merger and listing)
- Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026)
- Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift)
- Annual Report FY25
Terms on this page
- Capital expenditure (capex)
- Credit rating
- Dividend payout ratio
- EBITDA
- FII and DII holding
- Free cash flow
- Market capitalisation
- Net debt
- Net profit
- Operating margin
Each explains the term in plain English, with the same number from other companies on Cityfort.
Go deeper
More detail from the same filings. Open any section.
11What it sells
11What it sells
What does Max Healthcare sell?
Hospital treatment
Inpatient stays and outpatient visits. In Q2 FY27 the network treated 98,464 inpatients and gave about 11.4 lakh outpatient consultations, on 5,518 operational beds.
Transplants
The company reports about 4,978 liver, 6,329 kidney and 2,348 bone-marrow transplants done to date.
Cancer care
Oncology was 20.9% of network inpatient gross revenue in Q2 FY27, down from 25.7% a year earlier.
Max Lab
Diagnostic tests in over 60 cities; it served over 7 lakh patients in Q2 FY27. Revenue was ₹66 crore in Q2 FY27.
Max@Home
Care services at home, in 15 cities. Revenue was ₹86 crore in Q2 FY27, up 37% on a year earlier.
Running partner hospitals
Max runs hospitals owned by societies under service agreements and earns fees from them. Their own revenue sits outside consolidated revenue.
What it does
- Does: Runs hospitals in Delhi NCR, Mumbai, Lucknow, Nagpur, Mohali, Bathinda, Dehradun and Bhubaneswar
- Does: Treats patients from abroad: international patients were 10.2% of network hospital revenue in Q2 FY27
- Does: Runs diagnostic labs (Max Lab) and home care (Max@Home)
- Does: Runs the Mohali and Bathinda hospitals in partnership with the Government of Punjab
What it does not do
- Does not: Own every hospital in its network: partner hospitals belong to societies it does not control
- Does not: Make medicines or medical devices: it buys them, and they took ₹1,790 crore in FY26
- Does not: Come to the market through an IPO: it listed in Aug 2020 after a court-approved merger
- Does not: Report revenue per occupied bed any more: from Q2 FY27 it reports revenue per inpatient instead
12How the money flows
12How the money flows · FY26
How does money flow through Max Healthcare?
Money in
- Revenue from operations₹8,373 cr
- Other income₹163 cr
The company
Max Healthcare
₹8,536 cr came in
Money out
- Drugs, consumables and implants₹1,790 cr
- Doctors' professional and consultancy fees₹1,794 cr
- Employee costs₹1,357 cr
- Other running costs, incl. ₹48 crore of one-off charges₹1,238 cr
- Depreciation and interest₹682 cr
- Income tax₹233 cr
- Net profit₹1,442 cr
- In FY26 Max Healthcare's hospitals and services brought in ₹8,373 crore, plus ₹163 crore of other income.
- Drugs, consumables and implants took ₹1,790 crore, and doctors' fees ₹1,794 crore.
- Staff cost ₹1,357 crore, and other running costs ₹1,238 crore, including ₹48 crore of one-off charges.
- Depreciation of buildings and equipment plus interest took ₹682 crore, and income tax ₹233 crore.
- What was left was ₹1,442 crore of profit.
13What it needs to run
13What it needs to run
What does Max Healthcare need to run?
Hospital beds in big cities
Network bed capacity was 6,184 on 30 Sep 2026, of which 5,518 were operational. About 73% of beds are in metro markets, the FY26 annual report says.
Doctors
Doctors' professional and consultancy fees were ₹1,794 crore in FY26, about ₹21 of every ₹100 that came in.
People
The FY26 sustainability report (BRSR) counts 19,902 employees and workers at the parent company alone; it does not cover subsidiaries.
Money for new beds
Capex was ₹1,485 crore in FY26. The Aug 2026 presentation estimates ₹6,961 crore for planned beds from FY27 to FY30, excluding land.
Approval from payers
Being on a scheme's or insurer's list (empanelment) lets a hospital treat its members. CGHS and ECHS disempanelled certain Max hospitals, the company says.
14Competitors and what protects it
14Competitors and what protects it
Who does Max Healthcare compete with?
Fortis Healthcare
NSE: FORTIS
Named by CARE Ratings as an established hospital brand Max competes with.
Apollo Hospitals Enterprise
NSE: APOLLOHOSP
Named by CARE Ratings as an established hospital brand Max competes with.
Global Health (Medanta)
NSE: MEDANTA
Named by CARE Ratings, as Medanta, as an established hospital brand Max competes with.
What protects the business
Each strength is scored 1 (weak) to 5 (strong) for the business, with the reason. It is not a rating of the share.
- Hospitals in big cities4 of 5
About 73% of beds are in metro markets (FY26 annual report). CARE puts over 75% of network bed capacity in metros, especially Delhi NCR.
- Complex treatments4 of 5
The company reports about 4,978 liver, 6,329 kidney and 2,348 bone-marrow transplants done to date.
- Steady bed occupancy3 of 5
Network occupancy was between 74% and 77% in each quarter from Q3 FY25 to Q2 FY27, while beds were added.
- Patients from abroad3 of 5
International patients were 10.2% of network hospital revenue in Q2 FY27, up from 9.2% a year earlier.
- Access to borrowing4 of 5
CARE reaffirmed its AA+ (Stable) rating on Max's long-term bank facilities in Oct 2026, and assessed its liquidity as "Strong" in Oct 2025.
Weak spot
Dependence on the Delhi region
Hospitals in the Delhi region had 2,676 of the network's 5,518 operational beds in Q2 FY27. CARE lists concentration in metros, especially Delhi NCR, as a weakness.
Sources (9)
- CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025)
- Integrated Annual Report FY26
- Press release and Earnings Update, Q2 FY27
- Press release and Earnings Update, Q1 FY27
- Press release and Earnings Update, Q4 FY26
- Press release and Earnings Update, Q3 FY26
- Press release and Earnings Update, Q2 FY26
- Press release and Earnings Update, Q4 FY25
- Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026)
15Where growth could come from
15Where growth could come from
Where could Max Healthcare's growth come from?
Max Healthcare's Aug 2026 investor presentation plans 601 more beds in FY27, 500 in FY28, 927 in FY29 and 1,981 in FY30, reaching over 10,000 beds by FY30. It estimates the cost at ₹6,961 crore, excluding land and routine capex. Management said on the 6 Feb 2026 call: "by FY '28, we should be hitting 8,000."
New towers at existing hospitals
WorkingNetwork operational beds 5,518 on 30 Sep 2026, up from 4,760
A 400-bed tower at Max Smart, Saket, opened in Apr 2026, and a 160-bed tower at Mohali is fully running. Abhay Soi said on 3 Nov 2026 that 260 new Max Smart beds broke even on EBITDA within 3 months.
Status: Working, on track against what the company said.
New hospital at Sector-56, Gurgaon
Behind500 beds; first phase moved from H1 FY27 to the end of FY27
On 6 Feb 2026 management expected the first phase by the end of H1 FY27. On 3 Nov 2026 it said phased commissioning should start by the end of FY27.
Status: Behind, behind the company's own plan.
Bought hospitals: Bhubaneswar
EarlyQ2 FY27 revenue ₹38 crore, EBITDA ₹4 crore
Max bought 58.28% of Kalinga Hospital for ₹297.97 crore on 18 May 2026 and now holds about 66%. Its FY26 revenue before the purchase was ₹154 crore, management said. Occupancy was 52% in Q2 FY27, with 80 beds shut for renovation.
Status: Early, too early to judge.
Patients from abroad
Working₹307 crore in Q2 FY27, up from ₹231 crore
Network revenue from international patients rose to 10.2% of hospital revenue in Q2 FY27, from 9.2% a year earlier.
Status: Working, on track against what the company said.
Home care and diagnostics
WorkingMax@Home ₹86 crore in Q2 FY27, up 37%
Max@Home and Max Lab (₹66 crore in Q2 FY27) sell care and tests outside hospital stays.
Status: Working, on track against what the company said.
New hospitals in Lucknow and Pune
NewAbout ₹1,400 crore approved for about 712 beds, 21 May 2026
The board approved Phase I of a new hospital at Shaheed Path, Lucknow, with capacity for about 712 beds. On 18 Dec 2025 Max agreed to buy Yerawada Properties for a Pune hospital project, spending up to ₹1,020 crore including construction.
Status: New, recently announced.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
Sources (10)
- Investor presentation, Motilal Oswal Global Investor Conference (Aug 2026)
- Earnings call transcript, Q3 FY26 (call 6 Feb 2026)
- Press release and Earnings Update, Q2 FY27
- Press release and Earnings Update, Q2 FY26
- Press release and Earnings Update, Q4 FY26
- Earnings call transcript, Q2 FY27 (call 3 Nov 2026)
- Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift)
- Infusion of ~Rs 87.87 crore in Kalinga Hospital Ltd via rights issue (3 Sep 2026)
- Earnings call transcript, Q1 FY27 (call 14 Aug 2026)
- SPA to acquire 100% of Yerawada Properties Pvt Ltd (Pune hospital project) (18 Dec 2025)
16Financial strength and debt
16Financial strength · 31 Mar 2026
How much debt does Max Healthcare have?
- Total debt₹2,907 cr
- Cash and investments₹701 cr
- Net debt (debt minus cash)₹2,206 cr
- Net worth (shareholders' money)₹10,747 cr
- Debt to equity
- 0.27×
- ₹ of debt for every ₹1 of shareholders' money
- Net debt = borrowings excluding leases (₹2,907 crore) − cash and bank balances (₹701 crore), a Cityfort calculation (S1). Borrowings were ₹565 crore on 31 Mar 2023.
- Lease liabilities (rent owed under leases) were a further ₹572 crore. Including them, the company states debt-to-equity of 0.32.
- The company's own "network net debt", which covers partner hospitals and a put-option liability, was ₹1,908 crore on 31 Mar 2026 and ₹2,369 crore on 30 Sep 2026. Management said on 22 May 2026 that network net debt was "less than 1" times network EBITDA.
- On 30 Sep 2026 borrowings including leases were ₹3,795 crore and cash and bank balances ₹571 crore (half-year statement).
- Goodwill (₹3,488 crore) and other intangible assets (₹2,518 crore) are large. The company says fair-value accounting for the 2020 merger added ₹3,662 crore to the group's assets.
17Who owns it
17Who owns it · Q2 FY27
Who owns Max Healthcare?
- Promoters (founders or parent company)23.7%
- Foreign institutions (FII)40.5%
- Indian institutions (DII)31.0%
- Public and others4.8%
Promoter pledge
No promoter shares were pledged in Q2 FY27.
How ownership changed
* Pledged = share of the promoters' own holding reported as pledged. In older filings this can include shares “otherwise encumbered”; the governance flags say when.
Sources (12)
- Shareholding pattern as of 30 Sep 2026 (XBRL)
- Shareholding pattern as of 30 Jun 2026 (XBRL)
- Shareholding pattern as of 31 Mar 2026 (XBRL)
- Shareholding pattern as of 31 Dec 2025 (XBRL)
- Shareholding pattern as of 30 Sep 2025 (XBRL)
- Shareholding pattern as of 30 Jun 2025 (XBRL)
- Shareholding pattern as of 31 Mar 2025 (XBRL)
- Shareholding pattern as of 31 Dec 2024 (XBRL)
- Shareholding pattern as of 30 Sep 2024 (XBRL)
- Shareholding pattern as of 30 Jun 2024 (XBRL)
- Shareholding pattern as of 31 Mar 2024 (XBRL)
- Shareholding pattern as of 31 Dec 2023 (XBRL)
18What it does with profit
18What it does with profit
What does Max Healthcare do with its profit?
Dividend per share
₹2.00FY26
Dividend paid for each share, by financial year.
₹ per share
See the numbers
No buybacks or fund raises in the period covered.
19Governance signals
19Governance signals
What do Max Healthcare's governance filings show?
- Auditor
- S.R. Batliboi & Co. LLP, since 2025
- Auditor changes
- 20 May 2025: Deloitte Haskins & Sells → S.R. Batliboi & Co. LLP (Deloitte completed its five-year term at the 2025 AGM; the board recommended S.R. Batliboi for five years from that AGM.)
- Audit qualifications
- None reported
- Related-party dealings
- This page does not summarise the FY26 related-party note. Separately, the company runs partner hospitals owned by societies it does not control, and says it has significant financial exposure to them. It lent ₹420 crore to other healthcare providers in FY26.
- Credit rating
- CARE Ratings CARE AA+ (long-term bank facilities), CARE A1+ (short-term) (outlook Stable), 8 Oct 2026
A credit rating describes the company's ability to repay debt. It is not a rating of the share.
Flags to know about
disclosure · 30 Oct 2026
Headline figures include hospitals it does not own
Press releases headline "network" figures that include partner hospitals owned by societies. Their figures are unaudited. Q2 FY27 network gross revenue was ₹3,219 crore; consolidated revenue was ₹2,569 crore.
disclosure · 30 Oct 2026
Revenue per bed no longer reported
The Q2 FY27 earnings update reports average revenue per inpatient (₹2.31 lakh) instead of revenue per occupied bed per day, last given as ₹81,900 for Q1 FY27.
other · 3 Nov 2026
Tribunal petitions about Kalinga Hospital
Legal representatives of BRS Capital Two Pte. Limited filed petitions at NCLT Cuttack against Kalinga Hospital, the shareholder that sold Max its majority stake, and Max Healthcare. After a hearing on 30 Oct 2026, NCLT listed the matter for 14 Dec 2026.
Sources (9)
- Board outcome 20 May 2025: S.R. Batliboi & Co. LLP appointed statutory auditors (Deloitte term ends)
- Press release and Earnings Update, Q2 FY27
- Integrated Annual Report FY26
- Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026)
- CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025)
- Q2 FY27 consolidated results, XBRL (integrated filing)
- Press release and Earnings Update, Q1 FY27
- Reg. 30 update: NCLT Cuttack petitions by BRS Capital Two Pte relating to Kalinga Hospital, next date 14 Dec 2026 (3 Nov 2026)
- Reg. 30 update: NCLT Cuttack hearing adjourned (29 Oct 2026)
20What the market paid
20What the market paid · price as of 11 Nov 2026
What did the market pay for Max Healthcare on 11 Nov 2026?
Price as of 11 Nov 2026 (shown for education; prices change daily).
Price as of 11 Nov 2026: ₹928.30, the NSE closing price. Times 973,310,251 shares (30 Sep 2026), that is a market value of ₹90,352 crore. P/E divides the price by FY26 basic earnings per share (₹14.83): 62.6. P/B divides the market value by shareholders' equity on 31 Mar 2026 (₹10,747 crore): 8.4. These are Cityfort calculations from the 11 Nov 2026 NSE bhavcopy, the Sep 2026 shareholding pattern and the FY26 annual report.
- Share price
- ₹928.30
- Market value (market cap)
- ₹90,352 cr
- P/E
- 62.6×
- P/B
- 8.4×
Source: NSE capital-market bhavcopy, 11 Nov 2026; Shareholding pattern as of 30 Sep 2026 (XBRL); Integrated Annual Report FY26
21How it got here
21How it got here
How did Max Healthcare get here?
2000
Milestone
Starts operations
Max Healthcare says it commenced operations in 2000. The company was incorporated on 18 Jun 2001.
2020
Business-model change
Merger with Radiant Life Care
A scheme sanctioned by NCLT Mumbai on 17 Jan 2020 combined Radiant Life Care, Max Healthcare and Max India. It took effect on 1 Jun 2020.
2020
Milestone
Listed without an IPO
Shares issued under the scheme listed on NSE and BSE on 21 Aug 2020. In FY21 the company raised about ₹1,200 crore through a QIP.
2024
Milestone
Hospitals bought in Nagpur and Lucknow
Alexis hospital, Nagpur, became a wholly owned subsidiary on 20 Feb 2024. Control of the Sahara hospital in Lucknow followed on 4 Mar 2024.
2024
Milestone
Jaypee Healthcare, Noida
Max bought Jaypee Healthcare, then in insolvency, in two steps by 11 Nov 2024. It later paid ₹73.63 crore to YEIDA for permission to change the shareholding. The company, now Crosslay Remedies, was upgraded to CARE AA+ (Stable) in Oct 2026.
2026
Milestone
400-bed tower at Max Smart
A 400-bed tower at Max Smart Super Speciality Hospital, Saket, was commissioned in Apr 2026.
2026
Milestone
Kalinga Hospital, Bhubaneswar
Max bought 58.28% of the 250-bed Kalinga Hospital on 18 May 2026, and about 66% after a Sep 2026 rights issue.
Sources (11)
- Annual Report FY21 (year of the 2020 merger and listing)
- Integrated Annual Report FY26
- Annual Report FY24
- Strategic collaboration with Lakshdeep Group to acquire Jaypee Healthcare Ltd (13 Sep 2024)
- Board outcome: fund infusion in Jaypee Healthcare, Nirogi trust and Eqova (30 Jan 2025)
- Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift)
- Intimation: CARE upgrades Crosslay Remedies Ltd (formerly Jaypee Healthcare) to CARE AA+ (Stable) (9 Oct 2026)
- Press release and Earnings Update, Q4 FY26
- Board outcome: agreement to acquire ~58.39% of Kalinga Hospital Ltd, Bhubaneswar (8 Apr 2026)
- Infusion of ~Rs 87.87 crore in Kalinga Hospital Ltd via rights issue (3 Sep 2026)
- Earnings call transcript, Q2 FY27 (call 3 Nov 2026)
22Sources and changes
Where every number on this page comes from
Sources (55 documents)
- S1Integrated Annual Report FY26 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 8 Jul 2026
- S2Annual Report FY25 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 4 Jul 2025
- S3Annual Report FY24 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 26 Aug 2024
- S4Annual Report FY23 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 4 Sep 2023
- S5Annual Report FY21 (year of the 2020 merger and listing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 7 Sep 2021
- S6Q2 FY27 results (board outcome, quarter and half-year ended 30 Sep 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 30 Oct 2026
- S7Q2 FY27 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 30 Oct 2026
- S8Q1 FY27 results (board outcome, quarter ended 30 Jun 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 13 Aug 2026
- S9Q1 FY27 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 13 Aug 2026
- S10Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 21 May 2026
- S11Q4 FY26 / FY26 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 21 May 2026
- S12Q3 FY26 results (board outcome, quarter ended 31 Dec 2025) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 5 Feb 2026
- S13Q3 FY26 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 5 Feb 2026
- S14Q2 FY26 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 14 Nov 2025
- S15Q1 FY26 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 13 Aug 2025
- S16Q4 FY25 / FY25 consolidated results, XBRL (integrated filing) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 May 2025
- S17Q3 FY25 consolidated results, XBRL · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 30 Jan 2025
- S18Q4 FY24 / FY24 consolidated results, XBRL (cross-check of FY24) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 22 May 2024
- S19Q4 FY23 / FY23 consolidated results, XBRL (cross-check of FY23) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 17 May 2023
- S20Q4 FY22 / FY22 consolidated results, XBRL (FY22 as first reported) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 26 May 2022
- S21Press release and Earnings Update, Q2 FY27 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 30 Oct 2026
- S22Press release and Earnings Update, Q1 FY27 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 13 Aug 2026
- S23Press release and Earnings Update, Q4 FY26 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 21 May 2026
- S24Press release and Earnings Update, Q3 FY26 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 5 Feb 2026
- S25Press release and Earnings Update, Q2 FY26 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 14 Nov 2025
- S26Press release and Earnings Update, Q4 FY25 · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 May 2025
- S27Investor presentation, Motilal Oswal Global Investor Conference (Aug 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 17 Aug 2026
- S29Earnings call transcript, Q2 FY27 (call 3 Nov 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 9 Nov 2026
- S30Earnings call transcript, Q1 FY27 (call 14 Aug 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 Aug 2026
- S31Earnings call transcript, Q4 FY26 (call 22 May 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 29 May 2026
- S32Earnings call transcript, Q3 FY26 (call 6 Feb 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 12 Feb 2026
- S33Shareholding pattern as of 30 Sep 2026 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 16 Oct 2026
- S34Shareholding pattern as of 30 Jun 2026 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 17 Jul 2026
- S35Shareholding pattern as of 31 Mar 2026 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 Apr 2026
- S36Shareholding pattern as of 31 Dec 2025 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 15 Jan 2026
- S37Shareholding pattern as of 30 Sep 2025 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 18 Oct 2025
- S38Shareholding pattern as of 30 Jun 2025 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 18 Jul 2025
- S39Shareholding pattern as of 31 Mar 2025 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 15 Apr 2025
- S40Shareholding pattern as of 31 Dec 2024 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 Jan 2025
- S41Shareholding pattern as of 30 Sep 2024 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 18 Oct 2024
- S42Shareholding pattern as of 30 Jun 2024 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 16 Jul 2024
- S43Shareholding pattern as of 31 Mar 2024 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 17 Apr 2024
- S44Shareholding pattern as of 31 Dec 2023 (XBRL) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 15 Jan 2024
- S45CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025) · CARE Ratings Ltd · Tier 2: rating agency or regulator · 10 Oct 2025
- S46Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 9 Oct 2026
- S47Intimation: CARE upgrades Crosslay Remedies Ltd (formerly Jaypee Healthcare) to CARE AA+ (Stable) (9 Oct 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 9 Oct 2026
- S48Board outcome: agreement to acquire ~58.39% of Kalinga Hospital Ltd, Bhubaneswar (8 Apr 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 8 Apr 2026
- S49Infusion of ~Rs 87.87 crore in Kalinga Hospital Ltd via rights issue (3 Sep 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 3 Sep 2026
- S50Reg. 30 update: NCLT Cuttack petitions by BRS Capital Two Pte relating to Kalinga Hospital, next date 14 Dec 2026 (3 Nov 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 3 Nov 2026
- S51Reg. 30 update: NCLT Cuttack hearing adjourned (29 Oct 2026) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 29 Oct 2026
- S52SPA to acquire 100% of Yerawada Properties Pvt Ltd (Pune hospital project) (18 Dec 2025) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 18 Dec 2025
- S53Strategic collaboration with Lakshdeep Group to acquire Jaypee Healthcare Ltd (13 Sep 2024) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 13 Sep 2024
- S54Board outcome: fund infusion in Jaypee Healthcare, Nirogi trust and Eqova (30 Jan 2025) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 30 Jan 2025
- S55Board outcome 20 May 2025: S.R. Batliboi & Co. LLP appointed statutory auditors (Deloitte term ends) · Max Healthcare Institute Ltd (filed with NSE/BSE) · Tier 1: company or exchange filing · 20 May 2025
- S56NSE capital-market bhavcopy, 11 Nov 2026 · NSE (nsearchives.nseindia.com) · Tier 1: company or exchange filing · 11 Nov 2026
Changes to this page (v1 · 11 Nov 2026)
- v1 · 11 Nov 2026First version. (first version)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a SEBI-registered investment adviser.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Content is not an offer or solicitation to buy or sell any security.
Read the full disclaimerHide the full disclaimer
Cityfort publishes educational content that explains how listed companies work. Cityfort is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst and does not provide investment advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security.
All information is taken from publicly available sources, mainly company filings on BSE and NSE, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management are reported as statements, with their date and source; they are not our forecasts.